Callie Leigh-Anne Soltero, APRN

Callie Soltero practices at Baptist MD Anderson Cancer Physicians in Jacksonville, Florida.

Callie Soltero's NPI, 1972257574, was assigned on February 11, 2022. Callie Soltero holds Florida license APRN11017497.

Callie Soltero's primary practice is Baptist MD Anderson Cancer Physicians, at 1301 Palm Ave, Jacksonville, FL 32207 in Duval County. The practice phone is (904) 202-7300.

Callie Soltero's primary practice is Baptist MD Anderson Cancer Physicians in Jacksonville, Florida. Callie Soltero is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist MD Anderson Cancer Physicians. Dmand AI also links Callie Soltero to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Callie Soltero practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Callie Soltero's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Callie Soltero is licensed in Florida.

Dmand AI lists contact dermatitis, fibromyalgia and chronic pain, fluid and electrolyte imbalances, joint pain, lower back pain and nerve damage among the conditions Callie Soltero treats.

CMS data shows 364 Medicare services from Callie Soltero across 2 procedure codes in 2024, all of them office visits, for 230 Medicare patients. Medicare paid $22,498 for them. Every service was in an office.

CMS counts 230 Medicare patients who saw Callie Soltero in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Callie Soltero's median patient age at 70, with 100% women.

In 2024, Callie Soltero wrote 628 Medicare Part D claims for 234 patients. 98% of them were for generic drugs. CMS names the drug for 567 of them, across 6 drugs with 11 or more claims each, at $15,947 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Callie Soltero for performance year 2024, reported as part of a group. Callie Soltero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Callie Soltero as offering telehealth.